Skip to content

Modification of Cue Reactivity by Neurofeedback in Human Addiction

Modification of Cue Reactivity by Neurofeedback in Human Addiction

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04366505
Enrollment
88
Registered
2020-04-29
Start date
2021-07-01
Completion date
2023-06-30
Last updated
2021-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Use Disorder (AUD)

Keywords

alcohol use disorder, mindfulness-based intervention, neurofeedback, ventral striatum

Brief summary

The project is geared towards the understanding of how to increase cognitive control over cue reactivity and drug craving.

Detailed description

Project C04 aims at assessing the combined effect of two interventions targeting at reducing striatal cue reactivity and increasing cognitive control, namely mindfulness-based intervention and real-time fMRI neurofeedback. Firstly, the investigators will test whether a prior mindfulness-based intervention (WP1) is able to enhance the effect of rtfMRI NFB (WP2) and change the networks involved in regulation of cue reactivity by providing participants with explicit strategies. Secondly, the investigators will investigate whether this combined intervention leads to a better clinical outcome in terms of decreased heavy drinking days and a reduced sum of alcohol consumption three months later.

Interventions

BEHAVIORALTreatment as usual (TAU) and neurofeedback (NFB)

This group will receive Treatment as usual (TAU) and neurofeedback (NFB). During NFB, participants will be asked to regulate the signal from a target brain region during the presentation of alcohol cues. The ventral striatum was chosen as target region.

BEHAVIORALmindfulness-based relapse prevention (MBRP) and NFB

This group will receive MBRP and neurofeedback (NFB). MBRP consists of 5 extensive sessions of a specific manualized mindfulness-based intervention for alcohol dependent patients which will be carried out by trained psychologists and psychotherapists. During NFB, participants will be asked to regulate the signal from a target brain region during the presentation of alcohol cues. The ventral striatum was chosen as a target region.

BEHAVIORALTAU and sham NFB

This group will receive TAU and sham NFB. Sham NFB means that the signal displayed to the participant is based on activity in a control region, the auditory cortex, which is not involved in cue reactivity.

BEHAVIORALMBT and sham NFB

This group will receive MBRP and sham NFB. MBRP consists of 5 extensive sessions of a specific manualized mindfulness-based intervention for alcohol dependent patients which will be carried out by trained psychologists and psychotherapists. Sham NFB means that the signal displayed to the participant is based on activity in a control region, the auditory cortex, which is not involved in cue reactivity.

Sponsors

Central Institute of Mental Health, Mannheim
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

The participants will be allocated to one of two NFB groups (real NFB or control group) in a double-blind procedure. Participants of both groups will be further sub-divided into a mindfulness-based relapse prevention (MBRP) and a TAU group (single-blind).

Eligibility

Sex/Gender
ALL
Age
21 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* alcohol use disorder according to DSM-5 * ability to provide fully informed consent and to use self-rating scales * abstinent after detoxification for at least 5 days * sufficient understanding of the German language

Exclusion criteria

* lifetime history of DSM-5 bipolar, psychotic disorder, or substance dependence other than alcohol or nicotine dependence * current substance use other than nicotine and/or mild to moderate recreational use of cannabis as evidenced by positive urine test * current threshold DSM-5 diagnosis of any of the following disorders: current (hypo)manic episode, major depressive disorder, generalized anxiety disorder, PTSD, borderline personality disorder, or obsessive compulsive disorder * history of severe head trauma or other severe central neurological disorders (dementia, Parkinson's disease, multiple sclerosis) * pregnancy or nursing infants * use of medications or drugs known to interact with the CNS within the last 10 days, with testing at least four half-lives post last intake

Design outcomes

Primary

MeasureTime frameDescription
Neural Level: Blood Oxygen Level Dependent Signal within the ventral striatum3 consecutive days within up to two weeksChange of the ability to volitionally modulate brain activation to alcohol cues after training in the target area.
Clinical Level: Number of relapses3 monthsMBT and NFB will each lead to a reduced number of relapses during three months after treatment in comparison to the combination of TAU and sham NFB. The combined intervention is expected to lead to a larger reduction compared to the other groups. The investigators expect a higher number of days until relapse, a lower number of heavy drinking days and a lower amount of alcohol consumed by the participants during the follow-up period showing similar group differences.

Secondary

MeasureTime frameDescription
Form 90 (Miller, 1996)up to two weeksPrimary dependent measure of alcohol consumption
Baratt Impulsiveness Scale (BIS-15) (Meule et al., 2011)up to two weeksQuestionnaire assessing personality/behavioral construct of impulsivity. Scores range from 15 to 60. The BIS-15 has a four-point rating scale with a minimum value of 1 (1 = seldom/never) to a maximum of 4 (4 = almost always/always). Lower scores indicate less impulsivity and higher score mean more impulsivity.
Sensory Inventory (SI): self-assessment of sensory sensitivity for adults and adolescents (Zamoscik et al., 2017)up to two weeksQuestionnaire on self-assessment of sensory sensitivity. Minimum value: 1 representing never. maximum value: 7 representing almost always. Higher scores indicate higher sensitivity for sensory influences.
General depression scale (german: Allgemeine Depressionsskala) (Radloff, 1977)up to two weeksSelf-assessment of depressive symptoms. minimum: 0 representing seldom, maximum: 3 representing mostly. Higher scores indicate stronger depression.
Positive and Negative Affect Schedule (PANAS) (Watson et al., 1988)up to two weeks.measures mood/emotion. minimum: 1 representing not at all, maximum: 5 representing very much. Depending on the item, higher scores represent higher levels of positive affect and lower scores represent lower levels of negative affect.
Perceived Stress Scale (PSS) (Cohen et al., 1983)up to two weeksmeasures stress. minimum: 1 representing never. maximum: 5 representing quite often. Higher scores indicate higher levels of perceived stress.
Behavioral Inhibition/Approach System (BIS/BAS) (Carver & White, 1994)up to two weeksassessing individual differences in the sensitivity of the behavioral approach and the behavioral avoidance system.
Fagerström Test of Nicotine Dependence (Heatherton et al., 1991)up to two weeksassessing nicotine dependence
Visual Craving Scaleup to two weeksVisual Analogue Scale for craving
Functional changes in brain networksup to two weeksFunctional changes in brain networks related to cognitive control during cognitive task performance between baseline and post-neurofeedback fMRI sessions.
Dot-probe task with alcohol stimuliCollected once during the baseline assessmentChange in attentional bias to alcohol-related cues.
Dimensional card sorting task (Zelazo, 2006)Collected once during the baseline assessmentNeuropsychological test
Cue reactivity task (Vollstädt-Klein et al., 2011)2 timepoints: Before and after 2 weeks of neurofeedback.fMRI task. Change in BOLD during cue reactivity task.
Alcohol Abstinence Self-Efficacy Scale (DiClemente et al., 1994)2 weeksmeasure of craving. minimum: 1 representing not at all, maximum: 5 representing enormous. Higher scores indicate a high perceived temptation to drink.
Alcohol Urge Questionnaire (Bohn et al., 1995)2 weeksmeasure of craving
Alcohol Dependence Scale (Ackermann et al., 1999)2 weeksmeasure of craving. Range/response options vary depending on the question. Higher scores are predictive of DSM diagnosis of alcohol dependence.
German Inventory of Drinking Situations (DITS-40) (Victorio-Estrada, 1993)2 weeksmeasure of craving. minimum: 0 representing never, maximum: 3 representing almost always. Higher scores indicate a higher frequency to drink.
Craving Automated Scale for Alcohol (CASA) (Vollstädt-Klein et al., 2015)2 weeksmeasure of craving. minimum: 0 representing never, maximum: 5 representing always. Higher scores indicate automated craving.
Vocabulary testCollected once during the baseline assessmentNeuropsychological test
Drinking typeup to two weeksShort question on which kind of drinking type the participant identifies with the most

Countries

Germany

Contacts

Primary ContactPeter Kirsch, Prof. Dr.
peter.kirsch@zi-mannheim.de+49-621/1703
Backup ContactFalk Kiefer, Prof. Dr.
falk.kiefer@zi-mannheim.de+49-621/1703

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026